Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1990 Jan;79(1):28–34. doi: 10.1111/j.1365-2249.1990.tb05122.x

Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease.

K Hamzaoui 1, K Ayed 1, A Slim 1, M Hamza 1, J Touraine 1
PMCID: PMC1534721  PMID: 2154346

Abstract

Interferon-gamma (IFN-gamma) titres in 20 patients with active Behçet's disease were examined and compared with those of 20 normal donors. Sera from Behçet's disease patients revealed an IFN-gamma increase but no correlation between IFN level and natural killer (NK) activity. The analysis of lymphocyte subsets by monoclonal antibodies registered an increase of CD8+ T subpopulation and cells co-expressing CD8(+)-Leu7a+ markers. Moreover, a high number of cells expressing CD25+ and HLA-DR+ phenotype has been noted in patients with active Behçet's disease. Serological analysis showed a high level of IgG antibodies to HSV-1. The increase of IFN-gamma titre, the high number of activated T cells and the increasing level of IgG antibodies to HSV-1 are important manifestations during the active stage of Behçet's disease. These findings are discussed in relation to the immunopathogenesis of Behçet's disease.

Full text

PDF
34

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bacon T. H., Ozbakir F., Elms C. A., Denman A. M. Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome. Clin Exp Immunol. 1984 Sep;57(3):541–547. [PMC free article] [PubMed] [Google Scholar]
  2. Denman A. M., Fialkow P. J., Pelton B. K., Salo A. C., Appleford D. J., Gilchrist C. Lymphocyte abnormalities in Behçet's syndrome. Clin Exp Immunol. 1980 Oct;42(1):175–185. [PMC free article] [PubMed] [Google Scholar]
  3. Eglin R. P., Lehner T., Subak-Sharpe J. H. Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral ulcers. Lancet. 1982 Dec 18;2(8312):1356–1361. doi: 10.1016/s0140-6736(82)91268-5. [DOI] [PubMed] [Google Scholar]
  4. Hamzaoui K., Ayed K., Hamza M., Touraine J. L. Natural killer cells in Behçet's disease. Clin Exp Immunol. 1988 Jan;71(1):126–131. [PMC free article] [PubMed] [Google Scholar]
  5. Hooks J. J., Moutsopoulos H. M., Notkins A. L. The role of interferon in immediate hypersensitivity and autoimmune diseases. Ann N Y Acad Sci. 1980;350:21–32. doi: 10.1111/j.1749-6632.1980.tb20603.x. [DOI] [PubMed] [Google Scholar]
  6. Hylton W., Cayley J., Dore C., Denman A. M. 2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases. Ann Rheum Dis. 1986 Mar;45(3):220–224. doi: 10.1136/ard.45.3.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ohno S., Kato F., Matsuda H., Fujii N., Minagawa T. Detection of gamma interferon in the sera of patients with Behçet's disease. Infect Immun. 1982 Apr;36(1):202–208. doi: 10.1128/iai.36.1.202-208.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Pross H. F., Baines M. G., Rubin P., Shragge P., Patterson M. S. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol. 1981 Jan;1(1):51–63. doi: 10.1007/BF00915477. [DOI] [PubMed] [Google Scholar]
  9. Raedler A., Bredow G., Kirch W., Thiele H. G., Greten H. In vivo activated peripheral T cells in autoimmune disease. J Clin Lab Immunol. 1986 Apr;19(4):181–186. [PubMed] [Google Scholar]
  10. Rasmussen L. E., Jordan G. W., Stevens D. A., Merigan T. C. Lymphocyte interferon production and transformation after Herpes simplex infections in humans. J Immunol. 1974 Feb;112(2):728–736. [PubMed] [Google Scholar]
  11. Rodriguez M. A., Williams R. C., Jr Infection and rheumatic diseases. Clin Exp Rheumatol. 1989 Jan-Feb;7(1):91–97. [PubMed] [Google Scholar]
  12. Shimizu T., Ehrlich G. E., Inaba G., Hayashi K. Behçet disease (Behçet syndrome). Semin Arthritis Rheum. 1979 May;8(4):223–260. doi: 10.1016/0049-0172(79)90004-0. [DOI] [PubMed] [Google Scholar]
  13. Wilton J. M., Ivanyi L., Lehner T. Cell-mediated immunity in Herpesvirus hominis infections. Br Med J. 1972 Mar 18;1(5802):723–726. doi: 10.1136/bmj.1.5802.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Young C., Lehner T., Barnes C. G. CD4 and CD8 cell responses to herpes simplex virus in Behçet's disease. Clin Exp Immunol. 1988 Jul;73(1):6–10. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES